Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Scranton

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Opinion on Pharmacotherapy|December 25, 2009
Bromocriptine--unique formulation of a dopamine agonist for the treatment of type 2 diabetesRichard Scranton, Anthony Cincotta
The Annals of Pharmacotherapy|January 3, 2017
CommentSimon Dagenais, Richard Scranton
Plastic and Reconstructive Surgery|May 10, 2018
Transversus Abdominis Plane Blocks with Single-Dose Liposomal Bupivacaine in Conjunction with a Nonnarcotic Pain Regimen Help Reduce Length of Stay following Abdominally Based Microsurgical Breast ReconstructionMary DiGiorgi, Matthew Carangelo, Richard Scranton
Population Health Management|February 25, 2016
The American Opioid Epidemic: Population Health Implications and Potential Solutions. Report from the National Stakeholder PanelJanice L Clarke, Alexis Skoufalos, Richard Scranton
Drug, Healthcare and Patient Safety|December 31, 2020
Characterization of Device-Related Malfunction, Injury, and Death Associated with Using Elastomeric Pumps for Delivery of Local Anesthetics in the US Food and Drug Administration MAUDE DatabaseRichard Teames, Andrew Joyce, Richard Scranton, et al.
The Lancet. Psychiatry|June 12, 2025
Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trialLeslie Citrome, Nayana Nagaraj, Giovanni Traverso, et al.
Expert Opinion on Drug Safety|May 11, 2018
A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) databaseSimon Dagenais, Richard Scranton, Andrew R Joyce, et al.
Journal of Clinical Epidemiology|March 10, 2007
Veteran's affairs hospital discharge databases coded serious bacterial infections accuratelySebastian Schneeweiss, Ari Robicsek, Richard Scranton, et al.
Journal of the American Heart Association|January 15, 2013
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjectsJ Michael Gaziano, Anthony H Cincotta, Aaron Vinik, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2014
Development and validation of a risk score to identify patients at high risk for opioid-related adverse drug eventsHarold S Minkowitz, Richard Scranton, Stephen K Gruschkus, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Pharmacotherapy|December 25, 2009
Bromocriptine--unique formulation of a dopamine agonist for the treatment of type 2 diabetesRichard Scranton, Anthony Cincotta
The Annals of Pharmacotherapy|January 3, 2017
CommentSimon Dagenais, Richard Scranton
Plastic and Reconstructive Surgery|May 10, 2018
Transversus Abdominis Plane Blocks with Single-Dose Liposomal Bupivacaine in Conjunction with a Nonnarcotic Pain Regimen Help Reduce Length of Stay following Abdominally Based Microsurgical Breast ReconstructionMary DiGiorgi, Matthew Carangelo, Richard Scranton
Population Health Management|February 25, 2016
The American Opioid Epidemic: Population Health Implications and Potential Solutions. Report from the National Stakeholder PanelJanice L Clarke, Alexis Skoufalos, Richard Scranton
Drug, Healthcare and Patient Safety|December 31, 2020
Characterization of Device-Related Malfunction, Injury, and Death Associated with Using Elastomeric Pumps for Delivery of Local Anesthetics in the US Food and Drug Administration MAUDE DatabaseRichard Teames, Andrew Joyce, Richard Scranton, et al.
The Lancet. Psychiatry|June 12, 2025
Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trialLeslie Citrome, Nayana Nagaraj, Giovanni Traverso, et al.
Expert Opinion on Drug Safety|May 11, 2018
A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) databaseSimon Dagenais, Richard Scranton, Andrew R Joyce, et al.
Journal of Clinical Epidemiology|March 10, 2007
Veteran's affairs hospital discharge databases coded serious bacterial infections accuratelySebastian Schneeweiss, Ari Robicsek, Richard Scranton, et al.
Journal of the American Heart Association|January 15, 2013
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjectsJ Michael Gaziano, Anthony H Cincotta, Aaron Vinik, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2014
Development and validation of a risk score to identify patients at high risk for opioid-related adverse drug eventsHarold S Minkowitz, Richard Scranton, Stephen K Gruschkus, et al.
Pageof 2